ES2168254T3 - Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas. - Google Patents

Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas.

Info

Publication number
ES2168254T3
ES2168254T3 ES92114281T ES92114281T ES2168254T3 ES 2168254 T3 ES2168254 T3 ES 2168254T3 ES 92114281 T ES92114281 T ES 92114281T ES 92114281 T ES92114281 T ES 92114281T ES 2168254 T3 ES2168254 T3 ES 2168254T3
Authority
ES
Spain
Prior art keywords
new
desmetil
deoxitetraciclines
substitutes
amino substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92114281T
Other languages
English (en)
Spanish (es)
Inventor
Joseph J Hlavka
Phaik-Eng Sum
Yakov Gluzman
Ving J Lee
Adma A Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25092264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2168254(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2168254T3 publication Critical patent/ES2168254T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Moulding By Coating Moulds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES92114281T 1991-10-04 1992-08-21 Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas. Expired - Lifetime ES2168254T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77157691A 1991-10-04 1991-10-04

Publications (1)

Publication Number Publication Date
ES2168254T3 true ES2168254T3 (es) 2002-06-16

Family

ID=25092264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92114281T Expired - Lifetime ES2168254T3 (es) 1991-10-04 1992-08-21 Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas.

Country Status (27)

Country Link
EP (1) EP0536515B1 (cg-RX-API-DMAC10.html)
JP (1) JP3186863B2 (cg-RX-API-DMAC10.html)
KR (1) KR100269072B1 (cg-RX-API-DMAC10.html)
CN (1) CN1048240C (cg-RX-API-DMAC10.html)
AT (1) ATE211128T1 (cg-RX-API-DMAC10.html)
AU (1) AU654049B2 (cg-RX-API-DMAC10.html)
BR (1) BR1100853A (cg-RX-API-DMAC10.html)
CA (1) CA2079692C (cg-RX-API-DMAC10.html)
CL (1) CL2004001623A1 (cg-RX-API-DMAC10.html)
CZ (2) CZ309397A3 (cg-RX-API-DMAC10.html)
DE (4) DE122006000058I2 (cg-RX-API-DMAC10.html)
DK (1) DK0536515T3 (cg-RX-API-DMAC10.html)
ES (1) ES2168254T3 (cg-RX-API-DMAC10.html)
FI (1) FI114911B (cg-RX-API-DMAC10.html)
HU (2) HU219973B (cg-RX-API-DMAC10.html)
IL (3) IL103320A (cg-RX-API-DMAC10.html)
LU (1) LU91279I2 (cg-RX-API-DMAC10.html)
MX (1) MX9205532A (cg-RX-API-DMAC10.html)
NL (1) NL300244I2 (cg-RX-API-DMAC10.html)
NO (3) NO301472B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ244585A (cg-RX-API-DMAC10.html)
PL (4) PL172282B1 (cg-RX-API-DMAC10.html)
PT (1) PT536515E (cg-RX-API-DMAC10.html)
SG (1) SG52361A1 (cg-RX-API-DMAC10.html)
SK (2) SK280837B6 (cg-RX-API-DMAC10.html)
TW (1) TW275616B (cg-RX-API-DMAC10.html)
ZA (1) ZA927607B (cg-RX-API-DMAC10.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
WO1995022529A1 (en) * 1994-02-17 1995-08-24 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US8106225B2 (en) 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
JP5093953B2 (ja) 1999-09-14 2012-12-12 トラスティーズ オブ タフツ カレッジ 遷移金属を用いた化学反応による置換テトラサイクリンの調製方法
US6818634B2 (en) 2000-03-31 2004-11-16 Paratek Pharmaceuticals, Inc. 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
WO2001087824A2 (en) * 2000-05-15 2001-11-22 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
EA013908B1 (ru) 2000-07-07 2010-08-30 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1241160A1 (en) 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
AU2002250331A1 (en) 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP2298732A1 (en) 2001-03-13 2011-03-23 Paratek Pharmaceuticals, Inc. 7,9-Substituted tetracycline compounds
JP2004529927A (ja) * 2001-04-24 2004-09-30 パラテック ファーマシューティカルズ, インク. マラリアの治療のための置換されたテトラサイクリン化合物
WO2003005971A2 (en) 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
AU2002365120A1 (en) 2001-08-02 2003-07-15 Paratek Pharmaceuticals, Inc. Medicaments
EP2311798A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
JP2005526754A (ja) * 2002-03-08 2005-09-08 パラテック ファーマシューティカルズ インコーポレイテッド アミノメチル置換されたテトラサイクリン化合物
EP2295404A3 (en) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
CA2892332C (en) 2004-05-21 2017-03-21 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
US7534766B2 (en) 2004-11-05 2009-05-19 Wyeth Glucuronide metabolites and epimers thereof of tigecycline
AR057649A1 (es) 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
JP2009507793A (ja) * 2005-08-31 2009-02-26 ワイス グリシルサイクリンの9−アミノカルボニル置換誘導体
WO2007133797A2 (en) 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
US8518912B2 (en) 2007-11-29 2013-08-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as P2Y12 receptor antagonists
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
TW202332671A (zh) 2008-05-19 2023-08-16 美商Prtk Spv2公司 四環素化合物之甲苯磺酸鹽及同素異形體
PT2323972E (pt) * 2008-08-08 2013-10-09 Tetraphase Pharmaceuticals Inc Compostos de tetraciclina substituídos com c7-flúor
US9073829B2 (en) 2009-04-30 2015-07-07 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
US9315451B2 (en) 2009-05-08 2016-04-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
IN2012DN02502A (cg-RX-API-DMAC10.html) 2009-08-28 2015-08-28 Tetraphase Pharmaceuticals Inc
JP6025712B2 (ja) 2010-05-12 2016-11-16 レンペックス・ファーマシューティカルズ・インコーポレイテッド テトラサイクリン組成物
WO2013013504A1 (zh) * 2011-07-26 2013-01-31 山东亨利医药科技有限责任公司 替加环素衍生物
LT2890673T (lt) 2012-08-31 2019-04-10 Tetraphase Pharmaceuticals, Inc. Tetraciklino junginiai
EP3068370A2 (en) 2013-11-12 2016-09-21 Galenicum Health S.L. Stable pharmaceutical compositions
ES2978198T3 (es) 2016-10-19 2024-09-06 Tetraphase Pharmaceuticals Inc Formas cristalinas de eravaciclina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3579579A (en) * 1968-04-18 1971-05-18 American Cyanamid Co Substituted 7- and/or 9-amino-6-demethyl-6-deoxytetracyclines

Also Published As

Publication number Publication date
NO2017037I1 (no) 2017-08-01
DE69232302T4 (de) 2003-02-13
IL119590A0 (en) 1997-02-18
NL300244I1 (nl) 2007-01-02
IL103320A0 (en) 1993-03-15
HU9203110D0 (en) 1992-12-28
SK114999A3 (en) 2000-07-11
PL176333B1 (pl) 1999-05-31
EP0536515B1 (en) 2001-12-19
HU211172A9 (en) 1995-11-28
PL175957B1 (pl) 1999-03-31
PL296143A1 (en) 1993-05-31
HK1011348A1 (en) 1999-07-09
IL103320A (en) 1998-12-06
CL2004001623A1 (es) 2005-06-03
BR1100853A (pt) 1999-12-07
EP0536515A1 (en) 1993-04-14
CA2079692C (en) 2004-06-08
NL300244I2 (nl) 2007-01-02
ZA927607B (en) 1993-04-13
NO301472B1 (no) 1997-11-03
AU654049B2 (en) 1994-10-20
ATE211128T1 (de) 2002-01-15
DK0536515T3 (da) 2002-04-08
NO2006015I1 (no) 2006-11-27
SK280837B6 (sk) 2000-08-14
KR100269072B1 (ko) 2000-10-16
TW275616B (cg-RX-API-DMAC10.html) 1996-05-11
NO2006015I2 (no) 2011-03-14
NO923857L (no) 1993-04-05
CN1048240C (zh) 2000-01-12
MX9205532A (es) 1993-04-01
FI924454A0 (fi) 1992-10-02
PL172282B1 (pl) 1997-08-29
JPH05255219A (ja) 1993-10-05
FI114911B (fi) 2005-01-31
CN1072172A (zh) 1993-05-19
FI924454L (fi) 1993-04-05
CZ284209B6 (cs) 1998-09-16
NO2017037I2 (no) 2017-08-01
KR930007894A (ko) 1993-05-20
DE69232302D1 (de) 2002-01-31
CZ298492A3 (en) 1993-05-12
PL173311B1 (pl) 1998-02-27
HU219973B (hu) 2001-10-28
CZ284159B6 (cs) 1998-08-12
DE122006000058I2 (de) 2007-09-13
HUT63145A (en) 1993-07-28
SK298492A3 (en) 1995-03-08
IL119590A (en) 1999-03-12
LU91279I2 (fr) 2006-12-11
NZ244585A (en) 1995-07-26
NO923857D0 (no) 1992-10-02
PT536515E (pt) 2002-05-31
SK284826B6 (sk) 2005-12-01
JP3186863B2 (ja) 2001-07-11
DE69232302T2 (de) 2002-08-14
CA2079692A1 (en) 1993-04-05
SG52361A1 (en) 1998-09-28
DE122006000058I1 (de) 2007-01-18
AU2618392A (en) 1993-04-08
CZ309397A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
ES2168254T3 (es) Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas.
ES2081005T3 (es) 9-amino-7-sustituido-6-demetil-6-deoxitetraciclinas.
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2153076T3 (es) Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos.
DE68928874D1 (de) Biozide Zusammensetzungen
SV1998000153A (es) Proceso para la sintesis de 1,3-dioles
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2133426T3 (es) Combinaciones de productos activos fungicidas.
BR9203515A (pt) Processo para a producao de microcapsulas,agente pesticida,processo para combater ervas daninhas e microcapsulas
ES2179138T3 (es) Poliisocianatos que presentan grupos alofanato basados en difenilmetanodiisocianato con grupos isocianato predominante o completamente bloqueados.
HN1996000065A (es) Procedimiento e intermedios para preparar 1 bencil - 4 - (5, 6 demetoxi - indanon) 2 - il) metilpiperidina.
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2116496T3 (es) Proceso para la preparacion de 1,4-disubstituido-5(4h)-tetrazolinonas.
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BG105275A (en) Tan-1057 derivatives
ES2092263T3 (es) Analogos de la 15-deoxispergualina, su metodo de preparacion y su utilizacion en terapeutica como agentes inmunosupresores.
ES2192610T3 (es) Aminouracilos substituidos.
ES2188798T3 (es) Bifenileteroxazolinas y su empleo como agentes pesticidas.
ES2052720T3 (es) Nuevos compuestos heterociclicos con propiedades plaguicidas.
ES2195158T3 (es) Amidas de alfa-aminoacidos, su preparacion y el uso terapeutico de las mismas.
ES2053516T3 (es) Composiciones herbicidas de pendimetalina en combinacion de aceite y agua.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536515

Country of ref document: ES